Risk assessment on change of testing requirements for partner donation of reproductive cells
In May 2011, the European Commission asked ECDC to estimate the change in total exposure risk to hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) during reproductive cell handling and storage for secondary parties, if the current scheme of testing at each cell donation would change to testing partner donors of reproductive cells once or twice a year.
Based on initial findings, ECDC developed a model for the estimation of the residual risk of infection using data supplied by the European Society of Human Reproduction and Embryology.
Based on initial findings, ECDC developed a model for the estimation of the residual risk of infection using data supplied by the European Society of Human Reproduction and Embryology. Residual risks under the different testing procedures were compared in order to estimate the possible change in risk.
The ECDC risk assessment concludes that the estimated residual risks of an HIV, HBV or HCV infection being transmitted by undetected infection of reproductive cells donated for medically assisted reproduction was found to be relatively small, but not insignificant. If donors were tested at entry and then only every 24 months, an additional 0.5 (HIV), two (hepatitis B) and nine (hepatitis C) cases would be missed for each one million person years. If donors were tested every 12 months, the increases would be even smaller, thereby not constituting a significant increase in residual risk.
Rapid risk assessment: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo – fifth update
19 Jul 2019 - This is the fifth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the potential public health impact of Ebola virus disease for EU/EEA countries and assesses the likelihood of international expansion.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
2 Jul 2019 - In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
Rapid risk assessment: Dengue outbreak in Réunion, France, and associated risk of autochthonous outbreak in the EU/EEA
18 Jun 2019 - This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.